Career Enhancement Program
Career Enhancement Program
批准号:
10700016
负责人:
RICHARD H HAAS
金额:
$15.63万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-30 至 2024-08-31
关键词:
AgreementAmericanCertificationClinicClinicalClinical ResearchClinical TrialsCollaborationsColoradoDedicationsDiagnosisDiagnosticDoctor of PhilosophyEducational process of instructingFacultyFellowshipFellowship ProgramFloridaFoundationsFundingGenerationsGrantGrant Review ProcessHeadIndividualIndustryInstitutionInternetLearningMedical StudentsMedicineMentorsMentorshipMitochondriaMitochondrial DiseasesOrganPhysiciansPostdoctoral FellowRare DiseasesResearch PersonnelResearch SupportResearch TrainingScientistSeriesSiteSocietiesStudentsTelemedicineTrainingTranslational ResearchUnited States National Institutes of HealthUniversitiesVideoconferencingWorkcareerclinical developmentclinical translationclinical trial readinesscourse developmentdidactic educationdoctoral studentexperienceinterestlecturesmedical schoolsmeetingsmemberpatient orientedprofessorprogramssymposiumtraining opportunitytranslational medicinevolunteer
中文摘要
NAMDC职业提升方案由以下部分组成:
1. NAMDC奖学金计划为高级博士后提供独特的培训机会
我们预计临床研究员将在学术领域晋升到主治/助理教授级别,
作为训练有素的临床科学家。重点是转化医学,诊断教学
专业知识和临床试验专业知识的发展。我们的目标是培养新一代的第一个
临床科学家将有能力推动有前途的线粒体新疗法,
进入临床竞技场。10个培训地点正在合作开展这一方案。这些网站;哥伦比亚,
圣地亚哥、西雅图、克利夫兰、汉密尔顿、CHOP、贝勒、科罗拉多大学、马约诊所和
佛罗里达大学都是线粒体医学领域的领先机构。世界知名
在每个地方都可以找到教师。我们目前的研究员将和2个以前的研究员参加了RDCRN
培训课程,他们提出了他们的工作总结。
2.该奖学金计划是由远程医疗会议举行,涉及所有联盟网站,
每月Zoom视频会议。这些会议都是由教师,学生和国家卫生研究院出席
各位代表。参加者是RDCRN的受训人员。
3.职业提升包括(A)增加关于临床试验准备的教学核心讲座系列
将作为在线系列讲座提供。佛罗里达大学的彼得·斯塔普尔博士
自愿领导这门课程的开发他有多年的NIH和行业赞助的临床
审判经验。(B)10个职业发展网站的主管已同意发布一份
关于线粒体疾病管理的综合系列讲座。(C)线粒体医学
社会(MMS)目前正在开发一系列器官特异性线粒体疾病讲座是CME-
由UMDF认证并在线提供。
4. UMDF提供的资金将用于吸引年轻医生,医学生,MD/PhD
学生和最近的毕业生前往医学院的线粒体医学领域。我们计划
每年为NAMDC 2个职业提升站点的候选人提供2万美元的个人赠款。
提案将由一个现场董事委员会沿着UMDF赠款审查过程进行审查。在
此外,将在UMDF年会的第二天举行年度务虚会,
获奖者和NAMDC研究员可以与现场负责人互动并向他们介绍自己的工作。
英文摘要
The NAMDC Career Enhancement Program consists of the following components:
1. The NAMDC Fellowship Program which offers a unique training opportunity to senior postdoctoral
clinical fellows who we anticipate will move on to the attending/assistant professor level in an academic
setting as well-trained clinician scientists. The focus is on translational medicine, teaching of diagnostic
expertise and the development of clinical trials expertise. We aim to train the first of a new generation of
clinician scientists who will be well equipped to move the promising new treatments for mitochondrial
disease into the clinical arena. Ten training sites are collaborating in this program. These sites; Columbia,
San Diego, Seattle, Cleveland, Hamilton, CHOP, Baylor, University of Colorado, Mayo Clinic and the
University of Florida are all leading institutions in the field of mitochondrial medicine. World renowned
faculty are to be found at each site. Our current fellow will and 2 prior fellows have participated in RDCRN
training course where they present a summary of their work.
2. The fellowship program is held together by telemedicine conferences involving all consortium sites with
monthly Zoom video conferencing. These conferences are well attended by faculty, students and NIH
representatives. Participation is offered to RDCRN trainees.
3. Career enhancements include (A) The addition of a didactic core lecture series on Clinical Trial readiness
which will be available as an online lecture series. Dr. Peter Stacpoole at the University of Florida has
volunteered to head this course development. He has many years of NIH and industry sponsored clinical
trials experience. (B) The directors of the 10 Career Enhancement Sites have agreed to post a
comprehensive series of lectures on management of mitochondrial disease. (C) The Mitochondrial Medicine
Society (MMS) is currently developing a series of organ-specific mitochondrial disease lectures to be CME-
certified by the UMDF and made available on-line.
4. Funds to be provided by the UMDF will be used to attract young physicians, medical students, MD/PhD
students and recent graduates heading to medical school to the field of mitochondrial medicine. We plan to
provide $20K individual grants annually to candidates in 2 of our NAMDC Career Enhancement Sites.
Proposals will be reviewed by a committee of Site Directors along with the UMDF grant review process. In
addition, an annual retreat will take place on the day following the UMDF annual meeting where the
awardees and the NAMDC fellow can interact with and present their work to the site directors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phase 2 Study of Levetiracetam for Neonatal Seizures
-
批准号:8545585
-
项目类别:
-
资助金额:$39.91万
-
财政年份:2012
-
负责人:RICHARD H HAAS
-
依托单位:
Phase 2 Study of Levetiracetam for Neonatal Seizures
-
批准号:8730477
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2012
-
负责人:RICHARD H HAAS
-
依托单位:
Phase 2 Study of Levetiracetam for Neonatal Seizures
-
批准号:8417621
-
项目类别:
-
资助金额:$39.96万
-
财政年份:2012
-
负责人:RICHARD H HAAS
-
依托单位:
Career Enhancement Program
-
批准号:10265501
-
项目类别:
-
资助金额:$15.77万
-
财政年份:2011
-
负责人:RICHARD H HAAS
-
依托单位:
Career Enhancement Program
-
批准号:10023972
-
项目类别:
-
资助金额:$15.74万
-
财政年份:2011
-
负责人:RICHARD H HAAS
-
依托单位:
Career Enhancement Program
-
批准号:10472608
-
项目类别:
-
资助金额:$15.76万
-
财政年份:2011
-
负责人:RICHARD H HAAS
-
依托单位:
MITOCHONDRIAL MECHANISM IN HUMAN LACTIC ACIDOSIS LABORATORY STUDIES
-
批准号:8166789
-
项目类别:
-
资助金额:$0.16万
-
财政年份:2009
-
负责人:RICHARD H HAAS
-
依托单位:
LACTIC ACIDEMIA AND MITOCHONDIRAL MYOPATHY
-
批准号:8166777
-
项目类别:
-
资助金额:$0.38万
-
财政年份:2009
-
负责人:RICHARD H HAAS
-
依托单位:
LACTIC ACIDEMIA AND MITOCHONDIRAL MYOPATHY
-
批准号:7950906
-
项目类别:
-
资助金额:$0.91万
-
财政年份:2008
-
负责人:RICHARD H HAAS
-
依托单位:
LACTIC ACIDEMIA AND MITOCHONDIRAL MYOPATHY
-
批准号:7724870
-
项目类别:
-
资助金额:$1.6万
-
财政年份:2007
-
负责人:RICHARD H HAAS
-
依托单位:
LACTIC ACIDEMIA AND ITS CLINICAL COUNTERPARTS
-
批准号:7374124
-
项目类别:
-
资助金额:$1.42万
-
财政年份:2006
-
负责人:RICHARD H HAAS
-
依托单位:
PHARMACOKINETICS OF TWO FORMULATIONS OF COENZYME Q10
-
批准号:7606556
-
项目类别:
-
资助金额:$3.8万
-
财政年份:2006
-
负责人:RICHARD H HAAS
-
依托单位:
LACTIC ACIDEMIA AND ITS CLINICAL COUNTERPARTS
-
批准号:7606491
-
项目类别:
-
资助金额:$0.74万
-
财政年份:2006
-
负责人:RICHARD H HAAS
-
依托单位:
Lactic Acidemia and Its Clinical Counterparts
-
批准号:7045362
-
项目类别:
-
资助金额:$3.19万
-
财政年份:2003
-
负责人:RICHARD H HAAS
-
依托单位:
LACTIC ACIDEMIA AND ITS CLINICAL COUNTERPARTS
-
批准号:7205542
-
项目类别:
-
资助金额:$1.71万
-
财政年份:2003
-
负责人:RICHARD H HAAS
-
依托单位:
LACTIC ACIDEMIA AND ITS CLINICAL COUNTERPARTS
-
批准号:6117884
-
项目类别:
-
资助金额:$1.46万
-
财政年份:1998
-
负责人:RICHARD H HAAS
-
依托单位:
DICHLOROACETATE IN TREATMENT OF CONGENITAL LACTIC ACIDEMIA
-
批准号:6117921
-
项目类别:
-
资助金额:$1.46万
-
财政年份:1998
-
负责人:RICHARD H HAAS
-
依托单位:
LACTIC ACIDEMIA AND ITS CLINICAL COUNTERPARTS
-
批准号:6249054
-
项目类别:
-
资助金额:$1.64万
-
财政年份:1997
-
负责人:RICHARD H HAAS
-
依托单位:
DICHLOROACETATE IN TREATMENT OF CONGENITAL LACTIC ACIDEMIA
-
批准号:6279116
-
项目类别:
-
资助金额:$1.43万
-
财政年份:1997
-
负责人:RICHARD H HAAS
-
依托单位:
DICHLOROACETATE IN TREATMENT OF CONGENITAL LACTIC ACIDEMIA
-
批准号:6249107
-
项目类别:
-
资助金额:$1.64万
-
财政年份:1997
-
负责人:RICHARD H HAAS
-
依托单位:
海外基金